Starting a GLP-1 medication often raises more questions than the prescription itself answers. According to a study published in the New England Journal of Medicine, tirzepatide produced an average of 20.2% body weight reduction over 72 weeks, compared to 13.7% with semaglutide, in adults with obesity and without type 2 diabetes. Those are meaningful long-term outcomes. Month one, however, is a different story. It is less about rapid results and more about helping your body adjust to a new way of regulating appetite, digestion, and blood sugar.
Here is what that first month actually looks like for most patients, and what you can do to set yourself up for long-term success.
How These Medications Work
Both semaglutide and tirzepatide belong to a class of medications called GLP-1 receptor agonists. Semaglutide mimics a single gut hormone, while tirzepatide targets two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The dual-receptor action is what generally makes tirzepatide produce greater weight loss over time.
These medications work by signaling your brain to feel full sooner, slowing gastric emptying so meals stay with you longer, and stabilizing blood sugar levels. For a more detailed breakdown of the mechanisms behind GLP-1 therapy, see how medical weight loss works at Sota Wellness.
Week One: Low Dose, High Awareness
Providers start both medications at the lowest available dose. Tirzepatide typically begins at 2.5 mg once weekly. Semaglutide starts at a similarly conservative level. This is intentional. The goal in week one is tolerance, not transformation.
In the first few days, many patients notice:
- Reduced appetite soon after injection, sometimes within 24 to 48 hours
- Earlier fullness during meals, even with smaller portions
- Mild nausea, which is the most commonly reported early side effect
- Fatigue, as the body adapts to lower caloric intake and metabolic changes
Nausea tends to be most noticeable in the days immediately following each injection and often fades as the body adjusts. Eating smaller portions, choosing lighter foods like lean proteins and cooked vegetables, and staying hydrated can reduce discomfort significantly. Large, high-fat meals right after dosing typically make nausea worse.
Weeks Two Through Four: Adjusting and Observing
As the first month progresses, most patients settle into a new normal. Appetite continues to quiet down. The sensation of true hunger starts to feel different, less urgent, more manageable.
Common Side Effects and How to Manage Them
Digestive effects are the most frequently reported symptoms during the tirzepatide and semaglutide adjustment period. A meta-analysis published in PMC by the National Library of Medicine confirmed that gastrointestinal side effects such as nausea, constipation, diarrhea, and decreased appetite were mild to moderate in severity and transient, typically occurring at treatment initiation or during dose-escalation phases.
Practical strategies that help:
- Nausea: Eat slowly, stop before feeling full, and avoid fried or heavy meals. Ginger tea or plain crackers can help some patients settle the stomach.
- Constipation: Increase water intake and add fiber gradually through vegetables, oats, berries, and chia seeds.
- Fatigue: Focus on protein at each meal to maintain energy. Prioritize sleep. Light movement like short walks can help.
- Injection site discomfort: Rotate injection sites between the abdomen, thigh, and upper arm. Mild redness or swelling at the site is normal and usually resolves quickly.
How Much Weight Can You Expect to Lose in Month One?
Set realistic expectations for the first 30 days. Because the starting dose is intentionally low, weight loss in month one is often modest and varies widely from person to person. Some patients see the scale move within two weeks. Others notice non-scale changes first: steadier appetite, fewer cravings, more control over portion sizes. Both are meaningful signs the medication is doing its job.
Significant weight loss accumulates over several months as the dose is gradually increased and lifestyle habits are reinforced alongside the medication. Combining a nutritious diet and consistent movement with GLP-1 therapy consistently produces better outcomes than medication alone. Learn more about combining diet and exercise with GLP-1 medications for long-term success.
What to Watch for and When to Call Your Provider
Most side effects in month one are manageable and improve on their own. However, reach out to your provider if you experience:
- Severe or persistent vomiting that prevents adequate hydration
- Significant abdominal pain
- Signs of an allergic reaction
- Symptoms that feel unusual or worsening after each injection
Regular follow-up visits are built into a well-structured medical weight loss program for exactly this reason. Your provider will monitor your response, adjust dosing as needed, and address any concerns before they become setbacks.
Start Your GLP-1 Journey at Sota Wellness
The first month on tirzepatide or semaglutide is a foundation, not a finish line. Erin Britton, RN, FNP-C, and the team at Sota Wellness take a personalized approach to medical weight loss with GLP-1 medications, combining provider-led oversight with real support at every stage of treatment. Sota Wellness prescribes only FDA-approved medications, never compounded alternatives, so you can trust what you are putting in your body from day one.Ready to take the first step? Book an Appointment with Sota Wellness today.
Frequently Asked Questions
For most patients, nausea is at its worst during the first few days after each injection. It typically improves within the first two to four weeks as the body adjusts. Eating smaller, lower-fat meals and staying hydrated helps reduce intensity.
Some patients lose weight in the first month, while others see primarily appetite-related changes before the scale moves. Because starting doses are conservative, month one is mostly about adjustment. Meaningful, consistent weight loss typically builds over months two through six as dosing increases and habits solidify.
Semaglutide acts on one hormone receptor (GLP-1), while tirzepatide acts on two (GLP-1 and GIP). Clinical research consistently shows tirzepatide produces greater average weight loss over time, though both are effective options. Your provider will help determine which medication is the right fit based on your health history and goals.
Yes. Light to moderate exercise is encouraged from the start. Movement supports weight loss, improves mood, and helps maintain muscle mass as you lose fat. If fatigue is a factor in week one, start with short walks and build from there.
